1541 related articles for article (PubMed ID: 33949910)
1. Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) - a case series.
Kok EY; Srivaths L; Grimes AB; Vogel TP; Sexson Tejtel SK; Muscal E
Pediatr Hematol Oncol; 2021 Oct; 38(7):663-668. PubMed ID: 33949910
[TBL] [Abstract][Full Text] [Related]
2. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M
Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353
[TBL] [Abstract][Full Text] [Related]
3. Evans syndrome and immune thrombocytopenia in two patients with COVID-19.
Georgy JT; Jayakaran JAJ; Jacob AS; Gunasekaran K; Korula PJ; Devasia AJ; Iyadurai R
J Med Virol; 2021 May; 93(5):2642-2644. PubMed ID: 33634495
[No Abstract] [Full Text] [Related]
4. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
Feldstein LR; Tenforde MW; Friedman KG; Newhams M; Rose EB; Dapul H; Soma VL; Maddux AB; Mourani PM; Bowens C; Maamari M; Hall MW; Riggs BJ; Giuliano JS; Singh AR; Li S; Kong M; Schuster JE; McLaughlin GE; Schwartz SP; Walker TC; Loftis LL; Hobbs CV; Halasa NB; Doymaz S; Babbitt CJ; Hume JR; Gertz SJ; Irby K; Clouser KN; Cvijanovich NZ; Bradford TT; Smith LS; Heidemann SM; Zackai SP; Wellnitz K; Nofziger RA; Horwitz SM; Carroll RW; Rowan CM; Tarquinio KM; Mack EH; Fitzgerald JC; Coates BM; Jackson AM; Young CC; Son MBF; Patel MM; Newburger JW; Randolph AG;
JAMA; 2021 Mar; 325(11):1074-1087. PubMed ID: 33625505
[TBL] [Abstract][Full Text] [Related]
5. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study.
Abrams JY; Oster ME; Godfred-Cato SE; Bryant B; Datta SD; Campbell AP; Leung JW; Tsang CA; Pierce TJ; Kennedy JL; Hammett TA; Belay ED
Lancet Child Adolesc Health; 2021 May; 5(5):323-331. PubMed ID: 33711293
[TBL] [Abstract][Full Text] [Related]
6. Editorial: COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C).
Parums DV
Med Sci Monit; 2021 May; 27():e933369. PubMed ID: 34075014
[TBL] [Abstract][Full Text] [Related]
7. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
[TBL] [Abstract][Full Text] [Related]
8. Comparison of baseline laboratory findings of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis and multisystem inflammatory syndrome in children.
Aydın F; Çelikel E; Ekici Tekin Z; Coşkun S; Sezer M; Karagöl C; Kaplan MM; Tekgöz N; Kurt T; Özcan S; Kavurt AV; Özkaya Parlakay A; Çelikel Acar B
Int J Rheum Dis; 2021 Apr; 24(4):542-547. PubMed ID: 33550678
[TBL] [Abstract][Full Text] [Related]
9. Multisystem Inflammatory Syndrome in a Child with Scrub Typhus and Macrophage Activation Syndrome.
Gupta A; Gill A
J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33787904
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A
Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474
[TBL] [Abstract][Full Text] [Related]
11. Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe.
Valverde I; Singh Y; Sanchez-de-Toledo J; Theocharis P; Chikermane A; Di Filippo S; Kuciñska B; Mannarino S; Tamariz-Martel A; Gutierrez-Larraya F; Soda G; Vandekerckhove K; Gonzalez-Barlatay F; McMahon CJ; Marcora S; Napoleone CP; Duong P; Tuo G; Deri A; Nepali G; Ilina M; Ciliberti P; Miller O;
Circulation; 2021 Jan; 143(1):21-32. PubMed ID: 33166189
[TBL] [Abstract][Full Text] [Related]
12. Immune thrombocytopenia and COVID-19: Case report and review of literature.
Alonso-Beato R; Morales-Ortega A; Fernández FJH; Morón AIP; Ríos-Fernández R; Rubio JLC; Centeno NO
Lupus; 2021 Aug; 30(9):1515-1521. PubMed ID: 34053365
[TBL] [Abstract][Full Text] [Related]
13. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
Zhang QY; Xu BW; Du JB
World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
[TBL] [Abstract][Full Text] [Related]
14. Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Without Recurrence of Multisystem Inflammatory Syndrome in Children.
Buddingh EP; Vossen ACTM; Lamb HJ; van der Palen RLF; Brinkman DMC
Pediatr Infect Dis J; 2021 Dec; 40(12):e491-e492. PubMed ID: 34382616
[TBL] [Abstract][Full Text] [Related]
15. Differentiating multisystem inflammatory syndrome in children: a single-centre retrospective cohort study.
Roberts JE; Campbell JI; Gauvreau K; Lamb GS; Newburger J; Son MB; Dionne A
Arch Dis Child; 2022 Mar; 107(3):e3. PubMed ID: 34244164
[TBL] [Abstract][Full Text] [Related]
16. Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic.
Young TK; Shaw KS; Shah JK; Noor A; Alperin RA; Ratner AJ; Orlow SJ; Betensky RA; Shust GF; Kahn PJ; Oza VS
JAMA Dermatol; 2021 Feb; 157(2):207-212. PubMed ID: 33295957
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.
Mahévas M; Moulis G; Andres E; Riviere E; Garzaro M; Crickx E; Guillotin V; Malphettes M; Galicier L; Noel N; Darnige L; Terriou L; Guerveno C; Sanchis-Borja M; Moulinet T; Meunier B; Ebbo M; Michel M; Godeau B
Br J Haematol; 2020 Aug; 190(4):e224-e229. PubMed ID: 32678953
[No Abstract] [Full Text] [Related]
18. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
Zhao Y; Yin L; Patel J; Tang L; Huang Y
J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
[TBL] [Abstract][Full Text] [Related]
19. Management skin manifestation of multisystem inflammatory syndrome associated with SARS-CoV-2.
Bayram YE; Yildiz-Sevgi D; Yavuz A; Cancetin M; Gurler MY
Virol J; 2022 Jan; 19(1):9. PubMed ID: 34991644
[TBL] [Abstract][Full Text] [Related]
20. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
